Handelsbanken Fonder Ab Organon & Co. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Organon & Co. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 68,250 shares of OGN stock, worth $995,085. This represents 0.01% of its overall portfolio holdings.

Number of Shares

68,250

Previous 64,000 6.64%

Holding current value

$995,085

Previous $1.33 Million 1.43%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$18.65 - $23.03 $79,262 - $97,877	4,250 Added 6.64%	68,250 $1.31 Million
Q2 2024 Aug 05, 2024	SELL	$17.45 - $21.96 $36,645 - $46,116	-2,100 Reduced 3.18%	64,000 $1.33 Million
Q1 2024 May 13, 2024	BUY	$13.78 - $18.8 $279,734 - $381,640	20,300 Added 44.32%	66,100 $1.24 Million
Q4 2023 Feb 01, 2024	BUY	$10.95 - $17.32 $52,560 - $83,136	4,800 Added 11.71%	45,800 $660,000
Q1 2023 Apr 28, 2023	BUY	$21.42 - $32.08 $434,826 - $651,224	20,300 Added 98.07%	41,000 $964,000
Q4 2022 Feb 07, 2023	SELL	$23.31 - $28.61 $1.15 Million - $1.41 Million	-49,446 Reduced 70.49%	20,700 $578,000
Q3 2022 Oct 27, 2022	BUY	$23.4 - $34.25 $62,407 - $91,344	2,667 Added 3.95%	70,146 $1.64 Million
Q2 2022 Aug 03, 2022	BUY	$31.66 - $38.9 $312,357 - $383,787	9,866 Added 17.12%	67,479 $2.28 Million
Q1 2022 May 11, 2022	SELL	$30.45 - $39.36 $40,955 - $52,939	-1,345 Reduced 2.28%	57,613 $2.01 Million
Q4 2021 Feb 08, 2022	SELL	$28.67 - $37.13 $60,321 - $78,121	-2,104 Reduced 3.45%	58,958 $1.8 Million
Q3 2021 Nov 10, 2021	SELL	$28.63 - $35.64 $99,260 - $123,563	-3,467 Reduced 5.37%	61,062 $2 Million
Q2 2021 Aug 03, 2021	BUY	$28.45 - $38.0 $1.84 Million - $2.45 Million	64,529 New	64,529 $1.95 Million

Others Institutions Holding OGN

# of Institutions

793

Shares Held

192M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.71B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Organon & Co. Transaction History